Intestinal epithelial glycoproteins (None standardized; individual molecules such as "MUC2" (for Mucin 2) may be abbreviated)

Intestinal epithelial glycoproteins, most prominently the mucins (e.g., Mucin 2), form the protective mucus barrier covering the intestinal epithelium. These highly glycosylated proteins create a stratified layer: a dense, sterile inner layer that excludes bacteria and a looser, outer layer inhabited by commensal microbes. The glycoproteins regulate immune signaling, serve as nutrients for microbiota, and play key roles in tissue homeostasis, epithelial cell turnover, and barrier integrity. Alterations in glycosylation and protein stability are implicated in diseases such as IBD, inflammation, and gastrointestinal infections. They interact with host and microbial factors to balance protection, nutrient absorption, and microbial symbiosis. For precise therapeutic or research targeting, it is recommended to refer to defined molecular entities such as “Mucin 2 (MUC2)” rather than the non-specific “Mucosal Glycoproteins / Intestinal Epithelial Cell Surfaces.”

Other names

Mucin 2Mucosal glycoproteinsIntestinal mucinsMUC2Epithelial cell surface glycoproteinsEpithelial mucus layer proteins

Indirect modulation of glycoprotein production or secretion (e.g., anti-inflammatory drugs reduce mucin degradation). Restoration or stabilization of mucus barrier integrity. Modulation of glycosylation patterns. Inhibition of excessive shedding/apoptosis (therapeutic approaches in IBD).